HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Staphylococcal enterotoxin B toxic shock syndrome induced by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).

Abstract
We herein report a case of toxic shock syndrome (TSS) associated with the 2009 pandemic H1N1 (pH1N1) influenza virus and a community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection in a 16-year-old Vietnamese girl. Staphylococcal enterotoxin B (SEB) was detected in the patient's serum, and the level of anti-SEB antibodies was found to be elevated. A flow cytometric analysis showed evidence of activated SEB-reactive Vβ3+ and Vβ12+ T cells. These data suggest that the CA-MRSA-induced activation of SEB-reactive T cells may cause TSS in patients with pH1N1 virus infection. Moreover, this is the first report describing immunological confirmation of SEB contributing directly to TSS in a patient fulfilling the diagnostic criteria of TSS.
AuthorsTakeru Kashiwada, Ken Kikuchi, Shinji Abe, Hidehito Kato, Hiroki Hayashi, Taisuke Morimoto, Koichiro Kamio, Jiro Usuki, Shinhiro Takeda, Keiji Tanaka, Ken'ichi Imanishi, Junji Yagi, Arata Azuma, Akihiko Gemma
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 51 Issue 21 Pg. 3085-8 ( 2012) ISSN: 1349-7235 [Electronic] Japan
PMID23124156 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Enterotoxins
  • enterotoxin B, staphylococcal
Topics
  • Adolescent
  • Anti-Bacterial Agents (administration & dosage)
  • Community-Acquired Infections (drug therapy, etiology, microbiology)
  • Enterotoxins (toxicity)
  • Female
  • Humans
  • Influenza A Virus, H1N1 Subtype
  • Influenza, Human (complications)
  • Methicillin-Resistant Staphylococcus aureus
  • Pneumonia, Staphylococcal (drug therapy, etiology, microbiology)
  • Shock, Septic (drug therapy, etiology, microbiology)
  • Staphylococcal Infections (drug therapy, etiology, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: